Therakos, Inc. is an immunotherapy company focused on providing innovative treatment platforms that harness the power of each individual patient’s immune system to fight disease. We are the global leader in autologous immune cell therapy delivered through extracorporeal photopheresis (ECP). 

For more than 25 years, Therakos scientists, clinicians and engineers have been working to provide an innovative therapeutic platform that harnesses the potential within each patient to fight disease. Pioneered by Therakos, this therapeutic platform — extracorporeal photopheresis (ECP) — employs the patient’s own immune cells, which are processed with a light activated treatment outside the body before being returned to the patient, to modulate dysregulated immune function. 

Today, we supply the world’s only approved, fully-integrated systems for administering extracorporeal photopheresis (ECP), including the latest generation THERAKOS® CELLEX®Photopheresis System. These systems are used by academic medical centers, hospitals, and treatment centers in more than 30 countries and have already delivered over one million treatments globally. 

Therakos, Inc., is an Equal Opportunity/Affirmative Action Employer. All qualified candidates, including minorities, women, veterans, older workers and people with disabilities are encouraged to apply.